Amneal launches generic Entocort EC
Amneal Pharmaceuticals on Thursday introduced its generic Entocort EC (budesonide capsules). The product is indicated to treat Crohn’s disease and ulcerative colitis.
Amneal’s generic will be available in 3-mg dosage strength. Entocort EC and its generic equivalents had U.S. sales of roughly $187 million for the 12 months ended November 2017, according to IQVIA data.
Amneal’s generic will be available in 3-mg dosage strength. Entocort EC and its generic equivalents had U.S. sales of roughly $187 million for the 12 months ended November 2017, according to IQVIA data.